Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID 19 Impact on Psoriasis Patients, a Hospital Based Study

NCT05381402 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT05381402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05381402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID 19 Impact on Psoriasis Patients, a Hospital Based Study
Lead sponsor
Cairo University
Phase
Observational
Overall status
Unknown status
Start date
May 20, 2022
Completion date
June 10, 2022
Enrollment
230 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

the impact of covid19 on psoriasis patients